BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35185767)

  • 1. Clinical Predictors of Relapse in a Cohort of Steroid-Treated Patients With Well-Controlled Myasthenia Gravis.
    Su S; Lei L; Fan Z; Zhang S; Wen Q; Wang J; Lu Y; Di L; Wang M; Chen H; Da Y
    Front Neurol; 2022; 13():816243. PubMed ID: 35185767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study.
    Tan Y; Shi J; Huang Y; Li K; Yan J; Zhu L; Guan Y; Cui L
    Front Neurol; 2022; 13():877895. PubMed ID: 35775051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy choice and maintenance for generalized myasthenia gravis in China.
    Zhang C; Bu B; Yang H; Wang L; Liu W; Duan RS; Zhang M; Zeng P; Du C; Yang L; Shi FD
    CNS Neurosci Ther; 2020 Dec; 26(12):1241-1254. PubMed ID: 33103369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission and relapses of myasthenia gravis on long-term tacrolimus: a retrospective cross-sectional study of a Chinese cohort.
    Bi Z; Cao Y; Liu C; Gui M; Lin J; Zhang Q; Li Y; Ji S; Bu B
    Ther Adv Chronic Dis; 2022; 13():20406223221122538. PubMed ID: 36093262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT; Webb NJ; Woolley RL; Afentou N; Mehta S; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting minimal manifestation status induction in myasthenia gravis.
    Li Y; Yang S; Dong X; Li Z; Peng Y; Jin W; Chen D; Zhou R; Jiang F; Yan C; Yang H
    Ther Adv Neurol Disord; 2022; 15():17562864221080520. PubMed ID: 35371293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
    Frangiamore R; Giossi R; Vanoli F; Tourlaki A; Brambilla L; Maggi L; Mantegazza R
    Neurol Sci; 2021 May; 42(5):2081-2083. PubMed ID: 33404862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prednisone followed by thymectomy in myasthenia gravis.
    Mann JD; Johns TR; Campa JF; Muller WH
    Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China.
    Xin L; Meng QQ; Hu LH; Lin H; Pan J; Hao L; Liu PP; Qian W; Wang LW; Li ZS
    Pancreas; 2018 Oct; 47(9):1110-1114. PubMed ID: 30142120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis.
    Brauner S; Eriksson-Dufva A; Hietala MA; Frisell T; Press R; Piehl F
    JAMA Neurol; 2020 Aug; 77(8):974-981. PubMed ID: 32364568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission And relapse of myasthenia gravis on long-term azathioprine: An ambispective study.
    Gupta A; Goyal V; Srivastava AK; Shukla G; Behari M
    Muscle Nerve; 2016 Sep; 54(3):405-12. PubMed ID: 26802912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial.
    Wang Y; Zhao Z; Gao D; Wang H; Liao S; Dong C; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
    Semin Arthritis Rheum; 2020 Dec; 50(6):1513-1520. PubMed ID: 32113839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
    Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
    Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome.
    Takeda A; Takimoto H; Mizusawa Y; Simoda M
    Pediatr Nephrol; 2001 Nov; 16(11):888-93. PubMed ID: 11685595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
    Cortés-Vicente E; Rojas-Garcia R; Díaz-Manera J; Querol L; Casasnovas C; Guerrero-Sola A; Muñoz-Blanco JL; Bárcena-Llona JE; Márquez-Infante C; Pardo J; Martínez-Fernández EM; Usón M; Oliva-Nacarino P; Sevilla T; Illa I
    Ann Clin Transl Neurol; 2018 Jun; 5(6):710-716. PubMed ID: 29928654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of Long-term Maintenance Steroid Therapy Cessation in Patients With Autoimmune Pancreatitis: A Prospective Study.
    Hirano K; Tada M; Isayama H; Sasahira N; Umefune G; Akiyama D; Watanabe T; Saito T; Takagi K; Takahara N; Hamada T; Mizuno S; Miyabayashi K; Mohri D; Kogure H; Yamamoto N; Nakai Y; Arizumi T; Toda N; Koike K
    J Clin Gastroenterol; 2016 Apr; 50(4):331-7. PubMed ID: 26565969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of steroid-induced exacerbation in myasthenia gravis.
    Bae JS; Go SM; Kim BJ
    J Clin Neurosci; 2006 Dec; 13(10):1006-10. PubMed ID: 17074487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.